Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. Since its founding in 1885 by Albert Boehringer in Ingelheim, Germany, the family-owned company has been committed to researching, developing, manufacturing and marketing novel treatments for human and veterinary medicine, as well as biopharmaceutical contract manufacturing. Now, more than 125 years later, the company operates globally with 145 affiliates and more than 47,000 employees.
All of Boehringer Ingelheim’s efforts are focused on improving patients’ lives. We succeed by understanding patients’ needs, and meeting those needs with innovative medicines and best-in-class engagements, programs and services. As part of research and development activities for innovative drugs, the company focuses primarily on the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. Our animal health organization is second-largest in the U.S. with a portfolio that includes some of the most highly regarded and broadly used vaccines, parasite-control products and pharmaceuticals to help protect pets and livestock from disease.
We believe philanthropy is important and are on a mission to improve lives around the world. The Boehringer Ingelheim Cares Foundation is a private nonprofit organization that provides financial contributions to nonprofits that fill unmet needs of patients, families and communities. The Foundation also provides medicines to patients across the U.S. and around the world.
Having a presence in Ohio, Boehringer Ingelheim is excited to be part of the Ohio Chamber of Commerce and support the Chamber’s advocacy for businesses within the community.